KPRX - Kiora Pharmaceuticals Inc - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - KPRX (1372514)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
9 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2024-09-11
KPRXStengone Carmine N.DirP - Purchase$3.68+1,2501,250New+$4,600
2024-09-10
KPRXShapiro AronDirP - Purchase$3.60+3,0003,000New+$10,800
2024-08-19
KPRXWalters-Hoffert LisaDirP - Purchase$3.86+1,2501,250New+$4,825
2024-08-19
KPRXTyle PraveenDirP - Purchase$3.96+5,0005,014>999%+$19,800
2024-08-14
KPRXTosca MelissaCFOP - Purchase$3.21+2,00013,599+17%+$6,420
2024-06-14
KPRXTosca MelissaEVP FinanceP - Purchase$5.25+1003,979+3%+$525
2024-06-14
KPRXDaniels Eric JosephChief Development OfficerP - Purchase$5.29+1,43111,222+15%+$7,570
2024-06-13
KPRXParsons ErinDirP - Purchase$4.88+5,2605,260New+$25,669
2024-06-13
KPRXStrem Brian M.Pres, CEOP - Purchase$5.00+3,00014,531+26%+$14,997

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top